首页|期刊导航|癌症生物学与医学（英文版）|Drug resistance to antibody-drug conjugates:mechanisms,challenges,and perspectives

Drug resistance to antibody-drug conjugates:mechanisms,challenges,and perspectives

Yajing Liu Yuwei Liu Tingting Wu Xiaoming Bai Shuman Wang Luyun Zhang Zhiwen Fu Chen Shi

癌症生物学与医学（英文版）2026，Vol.23Issue(6)：833-864,32.

癌症生物学与医学（英文版）2026，Vol.23Issue(6)：833-864,32.DOI:10.20892/j.issn.2095-3941.2025.0707

Drug resistance to antibody-drug conjugates:mechanisms,challenges,and perspectives

Yajing Liu ¹Yuwei Liu ¹Tingting Wu ¹Xiaoming Bai ¹Shuman Wang ¹Luyun Zhang ¹Zhiwen Fu ¹Chen Shi¹

作者信息

1. Department of Pharmacy,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China||Hubei Province Clinical Research Center for Precision Medicine for Critical Illness,Wuhan 430022,China
折叠

摘要

关键词

Antibody-drug conjugates/drug resistance/combination strategies/cancer therapy

Key words

Antibody-drug conjugates/drug resistance/combination strategies/cancer therapy

引用本文复制引用

Yajing Liu,Yuwei Liu,Tingting Wu,Xiaoming Bai,Shuman Wang,Luyun Zhang,Zhiwen Fu,Chen Shi..Drug resistance to antibody-drug conjugates:mechanisms,challenges,and perspectives[J].癌症生物学与医学（英文版）,2026,23(6):833-864,32.

基金项目

This work was supported by the Joint Innovation Funding of the Natural Science Foundation of Hubei Province-Jiangsu-Hengrui Pharmaceuticals Company Ltd.(Grant No.2024AFD450)and the National Natural Science Foundation of China(Grant Nos.82073402 and 82204758). （Grant No.2024AFD450）

癌症生物学与医学（英文版）

ISSN：2095-3941

访问量0

下载量0

段落导航